Search

everythinglearnresearchcommunity

for

Search:↓

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

A new method was developed to make finasteride for treating hair loss.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

A new compound that could treat various androgen-related conditions was created and analyzed.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Anabolic steroids and SARMs can cause serious liver damage.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Counterfeit drugs for bodybuilders often contain incorrect or contaminated ingredients and look like real products.

Targeting neurosteroids may help prevent drug relapse.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.